Iranian Company Domestically Produces 12-Lead Electrocardiogram
15:00 - January 04, 2024

Iranian Company Domestically Produces 12-Lead Electrocardiogram

TEHRAN (ANA)- An Iranian company based at Pardis Technology Park in Tehran has designed and produced a 12-lead electrocardiogram device for quick diagnosis of heart conditions.
News ID : 4701

Heart attack is one of the most common medical emergencies in Iran whose quick diagnosis and rapid transfer of the patient to cardiac centers can prevent irreparable damage or death. For that, one of the knowledge-based companies that is located at Pardis Technology Park has successfully taken an effective step to improve health in the society by producing a 12 lead / channel electrocardiogram ECG machine with the trademark JamH1 for quick diagnosis of heart attacks.

Amir-Hossein Panahi, a senior researcher and one of the executive directors of the project to produce the 12-lead electrocardiogram device considered the production of vital signs monitoring devices to be one of the achievements of their company.

“With these monitors that the company has made, the specialists can learn about the symptoms and signals of cardiac conditions,” he said.

He said that his team of researchers started working on the project a few years ago, adding, “At the request of Iran Emergency Department a few years ago, a device was designed and produced to predict the possibility of heart attacks in those people who contacted the emergency center after feeling pain in their chest. It was provided to the Emergency Department of the country. When the emergency personnel visit the patient's home, this system sends the patient’s cardiograph information online to the cardiologist located in the emergency center, and the heart signal becomes visible.”

“According to the sent data, if a heart attack is diagnosed, instead of referring the patient to the hospital's emergency room, the patient will be transferred directly to the ‘data analysis’ of the hospital and results will be shared with the cardiologist,” Panahi added.

“All phases of the research, development and obtaining necessary licenses for this product have been done by our company. This product can be used both as pre-hospital care and as post-hospital care for all age groups under the supervision of a specialists,” the researcher concluded.

4155/i

Send comment